Global report - April 16, 2025
Joint Swedish response to the EU’s new life science strategy
Ahead of the EU Commission's presentation of a new strategy for life sciences, four industry organizations in Sweden, Lif – the research-based pharmaceutical companies, SwedenBIO, IKEM, and Swedish Medtech, have submitted a joint statement.
Global report - April 3, 2025
US market tariffs: Impact on the life science industry
At a White House press event on Wednesday April 2, President Trump advanced the next stage of his economic plan by unveiling baseline tariffs of 10% on the vast majority of goods imported to the US. After several years of increasing export figures, Sweden’s pharmaceutical exports now risk being severely affected by the Trump administration’s tariffs, warns the industry association SwedenBIO.
Global report - March 21, 2025
AstraZeneca to invest USD 2.5 billion in R&D centre in Beijing
AstraZeneca is establishing a new global strategic R&D centre in Beijing, its second in China and sixth worldwide.
Global report - March 21, 2025
The changing US regulatory environment: Amid Chaos, Signs of Opportunity
Notwithstanding political ‘hiccups,’ the US will remain the most favored market for Nordic life science companies, say experts.
Global report - March 10, 2025
#IWD 2025: Accelerate Action, Leadership & Women in Life Sciences
The theme for International Women’s Day (IWD) 2025 is “Accelerate Action”. At the current rate of progress, it will take until 2158 to achieve full gender parity, according to the World Economic Forum.
Global report - March 7, 2025
Nobel laureates sign joint appeal for transfer of Russian sanctioned state assets
The Nobel Prize laureates protest against Russia's war of invasion and the world's inaction, and they demand that EUR 300 billion in frozen Russian assets be given to Ukraine.